Clinical TrialID 3742

Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia

NCT00491569

Schizophrenias|Psychoses|Psychotic Disorders|Schizophrenic Disorders

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
3742
Evidence Id
3742
Core Evidence Id
3742
Source Clinical Trial Id
3715
Herb2 Clinical Trial Id
HBCT003715
Nct Id
NCT00491569
Title
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
Status
Completed
Phase
Phase 2
Study Result
No
Study Condition
Schizophrenias|Psychoses|Psychotic Disorders|Schizophrenic Disorders
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Intervention
DRUG: Sarcosine and D-serine
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
60
Outcome Measure
Total scores of Positive and Negative Syndrome Scale (PANSS) and Quality of Life (QOL), 6 weeks
Sponsor Collaborator
China Medical University Hospital|National Science Council, Taiwan|National Health Research Institutes, Taiwan
Funded By
OTHER
Location
China Medical University Hospital, Taichung, 404, Taiwan
Other Id
NSC-94-2314-B-039-026
Start Date
2005-01
Primary Completion Date
Completion Date
2006-12
First Posted
2007-06-26
Results First Posted
Last Update Posted
2007-06-26
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00491569
Title Cn
Title En
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia
Bilingual Status
semi_complete